Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor-induced disruption of the blood-brain barrier promotes host death.
Kim J, Chuang HC, Wolf NK, Nicolai CJ, Raulet DH, Saijo K, Bilder D. Kim J, et al. Among authors: nicolai cj. Dev Cell. 2021 Oct 11;56(19):2712-2721.e4. doi: 10.1016/j.devcel.2021.08.010. Epub 2021 Sep 7. Dev Cell. 2021. PMID: 34496290 Free PMC article.
Killer cells add fire to fuel immunotherapy.
Nicolai CJ, Raulet DH. Nicolai CJ, et al. Science. 2020 May 29;368(6494):943-944. doi: 10.1126/science.abc2502. Science. 2020. PMID: 32467380 No abstract available.
Millikelvin-resolved ambient thermography.
Tang K, Dong K, Nicolai CJ, Li Y, Li J, Lou S, Qiu CW, Raulet DH, Yao J, Wu J. Tang K, et al. Among authors: nicolai cj. Sci Adv. 2020 Dec 9;6(50):eabd8688. doi: 10.1126/sciadv.abd8688. Print 2020 Dec. Sci Adv. 2020. PMID: 33298452 Free PMC article.
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.
Hsu J, Hodgins JJ, Marathe M, Nicolai CJ, Bourgeois-Daigneault MC, Trevino TN, Azimi CS, Scheer AK, Randolph HE, Thompson TW, Zhang L, Iannello A, Mathur N, Jardine KE, Kirn GA, Bell JC, McBurney MW, Raulet DH, Ardolino M. Hsu J, et al. Among authors: nicolai cj. J Clin Invest. 2018 Oct 1;128(10):4654-4668. doi: 10.1172/JCI99317. Epub 2018 Sep 10. J Clin Invest. 2018. PMID: 30198904 Free PMC article.
Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.
Odegard JM, Kelley-Clarke B, Tareen SU, Campbell DJ, Flynn PA, Nicolai CJ, Slough MM, Vin CD, McGowan PJ, Nelson LT, Ter Meulen J, Dubensky TW Jr, Robbins SH. Odegard JM, et al. Among authors: nicolai cj. J Immunother. 2015 Feb-Mar;38(2):41-53. doi: 10.1097/CJI.0000000000000067. J Immunother. 2015. PMID: 25658613 Free PMC article.
Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cells.
Tareen SU, Kelley-Clarke B, Nicolai CJ, Cassiano LA, Nelson LT, Slough MM, Vin CD, Odegard JM, Sloan DD, Van Hoeven N, Allen JM, Dubensky TW Jr, Robbins SH. Tareen SU, et al. Among authors: nicolai cj. Mol Ther. 2014 Mar;22(3):575-587. doi: 10.1038/mt.2013.278. Epub 2013 Dec 6. Mol Ther. 2014. PMID: 24419083 Free PMC article.
13 results